ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.
This website contains forward-looking statements about potential therapeutic uses and effects of ProQR Therapeutics’ products, including but not limited to our technologies.
At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.
… of Miami Miller School of Medicine. Dr. Lam is a clinical scientist with expertise and translational research … and ophthalmic epidemiology. In addition to clinical studies, his research focus includes gene therapy, … and biomarkers. Dr. Lam has participated in numerous clinical trials in hereditary retinal disease and …
